MEET YOUR NEW AI CLINICAL ASSISTANT /// GET EARLY ACCESS
Tempus One

The first AI-enabled clinical assistant that provides access to patient insights directly at your fingertips.

GET EARLY ACCESS Broad availability coming in September
Tempus One

Smart technology to assist in clinical treatment decisions— anytime, anywhere.

Simple view into order status and signed out reports.

Access new reports immediately and receive updates on the status of a patient's report.

Rapid filtering of patient incidence by alteration, gene or diagnoses.

Review relevant cohorts of your patients for additional insight into decision making.

Quick access to patient information.

Get report information on actionable biomarkers along with MSI and TMB status.

Request test add-ons for an order.

Add an algorithmic test like HRD, a confirmatory germline test or a liquid biopsy test.

Feature coming soon

More insight into therapeutic options.

Learn more about personalized therapy options for a patient based on actionable biomarkers.

Understand potential adverse events to therapies.

Dive deeper into notable adverse events that may be relevant to your patient.

Feature coming soon

Up to date, real time notifications.

Get notified for new targeted therapies and clinical trial options.

Feature coming soon
GET EARLY ACCESS

Don't take our word for it. Hear how others are using Tempus One.

  • Asking Tempus One a verbal question about the status of a test, results for a specific patient, or to look at trends across several patients is super intuitive and easy to use.  It has helped with efficiently getting the real-time NGS answers I need in the clinic without the burden of digging through the chart or individual report.

    image description
    Thomas George, MD, FACP, University of Florida Cancer Center
  • Tempus One demonstrates the power of assistive technologies by simplifying the often complex process of ordering, obtaining, and interpreting genomic testing. The ability to have a voice assistant augment our efforts in delivering precision oncology allows us to unlock the power of artificial intelligence for direct clinical benefit for our patients.

    image description
    Sandip Patel, MD, UC San Diego Health
  • Tempus One is a great platform that allows me to personalize my patients care — in my office, in the community setting, at my fingertips — and to me, that is the future of oncology.

    image description
    Kamal Sharma, DO, The Oncology Institute, Lakeland, FL

Get early access

We will be provisioning early access to Tempus One at the 2023 ASCO® Annual Meeting. If you are attending, we can schedule a time to provision you onsite at our booth. Please arrive anytime between your selected time block.

If you are not attending, we can still provide you with early access. We will be in touch on scheduling a separate time to get you provisioned to Tempus One. 

We hope to see you soon.